- Home
- THAR vs AUUD Comparison
THAR vs AUUD Comparison
Compare THAR & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- AUUD
- Stock Information
- Founded
- THAR 2017
- AUUD 2012
- Country
- THAR United States
- AUUD United States
- Employees
- THAR N/A
- AUUD N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- AUUD Computer Software: Prepackaged Software
- Sector
- THAR Health Care
- AUUD Technology
- Exchange
- THAR Nasdaq
- AUUD Nasdaq
- Market Cap
- THAR 3.3M
- AUUD 2.9M
- IPO Year
- THAR 2022
- AUUD 2021
- Fundamental
- Price
- THAR $1.82
- AUUD $6.12
- Analyst Decision
- THAR Strong Buy
- AUUD
- Analyst Count
- THAR 1
- AUUD 0
- Target Price
- THAR $17.00
- AUUD N/A
- AVG Volume (30 Days)
- THAR 41.7K
- AUUD 66.5K
- Earning Date
- THAR 08-08-2025
- AUUD 08-06-2025
- Dividend Yield
- THAR N/A
- AUUD N/A
- EPS Growth
- THAR N/A
- AUUD N/A
- EPS
- THAR N/A
- AUUD N/A
- Revenue
- THAR N/A
- AUUD N/A
- Revenue This Year
- THAR N/A
- AUUD N/A
- Revenue Next Year
- THAR N/A
- AUUD N/A
- P/E Ratio
- THAR N/A
- AUUD N/A
- Revenue Growth
- THAR N/A
- AUUD N/A
- 52 Week Low
- THAR $0.95
- AUUD $2.88
- 52 Week High
- THAR $6.39
- AUUD $31.62
- Technical
- Relative Strength Index (RSI)
- THAR 64.36
- AUUD 49.64
- Support Level
- THAR $1.30
- AUUD $4.11
- Resistance Level
- THAR $1.46
- AUUD $4.54
- Average True Range (ATR)
- THAR 0.14
- AUUD 0.41
- MACD
- THAR 0.02
- AUUD -0.08
- Stochastic Oscillator
- THAR 96.17
- AUUD 30.77
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.